Vivoryon Therapeutics N.V. (AMS:VVY)
1.245
+0.015 (1.22%)
May 27, 2026, 1:13 PM CET
Vivoryon Therapeutics Employees
Vivoryon Therapeutics had 13 employees as of December 31, 2025. The number of employees decreased by 1 or -7.14% compared to the previous year.
Employees
13
Change (1Y)
-1
Growth (1Y)
-7.14%
Revenue / Employee
n/a
Profits / Employee
€681,000
Market Cap
36.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | -1 | -7.14% |
| Dec 31, 2024 | 14 | -1 | -6.67% |
| Dec 31, 2023 | 15 | 0 | - |
| Dec 31, 2022 | 15 | 0 | 0.67% |
| Dec 31, 2021 | 15 | -3 | -17.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Value8 | 2,009 |
| Morefield Group | 555 |
| Cabka | 486 |
| Ctac N.V. | 329 |
| Almunda Professionals | 175 |
| Alumexx | 71 |
| Global InterConnection Group | 12 |
| Bever Holding NV | 1 |
Vivoryon Therapeutics News
- 4 weeks ago - Vivoryon Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - Vivoryon Therapeutics Annual report: Q4 2025 - Filings
- 4 weeks ago - Vivoryon Therapeutics Earnings release: Q4 2025 - Filings
- 4 weeks ago - Vivoryon Therapeutics Slides: Q4 2025 - Filings
- 4 weeks ago - Vivoryon Therapeutics N.V. Reports Full Year 2025 Financial Results and Provides Business Update - Benzinga
- 2 months ago - Vivoryon Therapeutics Slides: Investor presentation - Filings
- 6 months ago - Vivoryon Therapeutics Earnings Call Transcript: Q3 2025 - Transcripts
- 6 months ago - Vivoryon Therapeutics Earnings release: Q3 2025 - Filings